Fig 2. Lives Saved in Increased Aspirin-Use Scenarios Relative to the Status Quo.

Difference in mortality of Guideline Adherence and Universal Eligibility scenarios with the Status Quo scenario for a thousand people representative of the American population at age 51. Confidence intervals are omitted for clarity.